Henry Schein (NASDAQ:HSIC) Price Target Raised to $80.00 at Jefferies Financial Group

Henry Schein (NASDAQ:HSIC) had its price target raised by Jefferies Financial Group from $77.00 to $80.00 in a research report released on Thursday,Benzinga reports. They currently have a hold rating on the stock.

Several other analysts also recently weighed in on HSIC. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho assumed coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Seven investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Trading Down 0.0 %

Shares of HSIC stock opened at $74.75 on Thursday. The business has a 50-day moving average price of $72.70 and a two-hundred day moving average price of $70.86. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.32 billion, a P/E ratio of 30.76, a price-to-earnings-growth ratio of 2.03 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the company posted $1.32 EPS. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year. Equities analysts anticipate that Henry Schein will post 4.78 EPS for the current fiscal year.

Insider Transactions at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Hedge Funds Weigh In On Henry Schein

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. FMR LLC grew its position in shares of Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after buying an additional 237,888 shares during the period. Southpoint Capital Advisors LP grew its holdings in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after purchasing an additional 600,000 shares during the period. Nuance Investments LLC increased its stake in shares of Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC increased its stake in shares of Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Henry Schein by 0.5% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock valued at $85,662,000 after purchasing an additional 6,184 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.